Clinical Trial Update: Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating postoperative zoledronic acid in breast cancer patients after neoadjuvant chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED